FLORIDA — A Miami woman has been sentenced for a $192 million Medicare fraud scheme, said the U.S. Department of Justice (DOJ).
Elizabeth Hernandez, 45, of Miami, was sentenced last month to 20 years in prison for her role in a scheme to defraud Medicare by submitting over $192 million in claims for genetic tests and durable medical equipment that patients did not need and telemedicine visits that never occurred, said the DOJ.
According to court documents and evidence presented at trial, Hernandez signed thousands of orders for medically unnecessary orthotic braces and genetic testing for Medicare beneficiaries she never spoke to, examined, or treated. As part of the scheme, telemarketing companies would contact Medicare beneficiaries to convince them to accept orthotic braces and genetic tests and would then send pre-filled orders for these products to Hernandez, who signed them, attesting that she had examined or treated the patients.
However, she had never spoken with many of the patients, and she often had others, including non-licensed individuals, sign her name to fraudulent orders. Hernandez also falsified information about beneficiaries’ symptoms and injuries in the orders.
According to the DOJ, during the period of the conspiracy, Hernandez ordered more cancer genetic tests for Medicare beneficiaries than any other provider in the nation. In 2020, when Medicare expanded its telemedicine coverage in response to the COVID-19 pandemic, Hernandez also billed Medicare for thousands of telemedicine visits she never performed, routinely billing over 24 hours of telemedicine in a single day.
Hernandez personally pocketed approximately $1.6 million in the scheme, which she used to purchase expensive cars, jewelry, home renovations, and travel, prosecutors said.
Acting Assistant Attorney General Nicole M. Argentieri of the Justice Department’s Criminal Division, Deputy Inspector General for Investigations Christian J. Schrank of the Department of Health and Human Services Office of Inspector General (HHS-OIG), and Assistant Director Michael Nordwall of the FBI’s Criminal Investigative Division made the announcement.
HHS-OIG and the FBI Miami Field Office investigated the case.
Assistant Chief Kate Payerle and Trial Attorney Andrea Savdie of the Criminal Division’s Fraud Section prosecuted the case.
